Document is current
Any future updates will be listed below
-
Authors
Wei, Miaoyan
Liu, Rujiao
Xu, Yunyun
Chen, Xiaobing
Liu, Chao
Bai, Xueli
Zhang, Xiaochen
Gao, Shuiping
Li, Jialin
Sheng, Zhen
Lian, Jianpo
Wang, Wenliang
Zhang, Jian
Shi, Si
Xu, Jin
Yu, Xianjun
-
Funding
Funding for this research was provided by:
Jiangsu Hengrui Medicine
- License Information
-
More Information
Article History
Received: 18 January 2024
Accepted: 22 August 2024
First Online: 4 September 2024
Declarations
:
: The protocol and all amendments were approved by the Ethics Committee of Fudan University Shanghai Cancer Center (1911210-13-2108C), Zhejiang Provincial People’s Hospital (2020YW011-A3), Henan Cancer Hospital (2020011002), Sun Yat-sen Memorial Hospital (2020-YW-025-004), and the First Affiliated Hospital, Zhejiang University School of Medicine (2021-573). The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. All patients provided written informed consent.
: Not applicable.
: Zhen Sheng, Jianpo Lian, and Wenliang Wang report being employed by Jiangsu Hengrui Pharmaceuticals. All other authors declare no competing interests.
